Market Overview:
Anal fissures are small tears or openings in the skin around the anal sphincter. They can cause pain and bleeding during and after bowel movements. Topical drugs are applied to the affected area and help speed up healing and relieve pain and itching.
Market key trends:
One of the key trends in the anal fissure treatment market is the preference for non-surgical treatments over surgical ones. Topical drugs are preferred as the first line treatment for anal fissures as they help heal anal fissures and relieve pain with fewer side effects than surgery. Calcium channel blockers are commonly used as they promote healing by reducing anal pressure and spasm. Lidocaine ointments also provide pain relief.
Segment Analysis
The global anal fissure treatment market is segmented based on drug type, end-user, and distribution channel. By drug type, the market is dominated by the calcium channel blockers segment due to its efficacy and minimal side effects. Calcium channel blockers such as nifedipine and diltiazem help reduce pain and promote healing of the fissure by relaxing the muscles of the anal sphincter.
The global Anal Fissure Treatment Market Size is estimated to be valued at US$ 1,039.3 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Key Takeaways
The global anal fissure treatment market is expected to witness high growth, exhibiting a CAGR of 5.3% over the forecast period, due to an increasing prevalence of gastrointestinal disorders.
Regional analysis
North America dominates the global market, accounting for over 40% share. This is attributed to the rising incidence of anal fissures and a robust healthcare system in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to growing healthcare expenditures and increasing accessibility to treatment options in developing countries such as China and India.
Key players
Key players operating in the anal fissure treatment market are Allergan, Novartis, Pfizer, Takeda Pharmaceutical Company, Cook Medical, Medtronic, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Sanofi, Merck, Abbott Laboratories, Bayer, Astellas Pharma, Aurobindo Pharma, Ferring Pharmaceuticals, Salix Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, and Boehringer Ingelheim.
Read More: https://www.ukwebwire.com/global-anal-fissure-treatment-market-trend-and-share-analysis/
